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Background: Clinical trials have shown the beneﬁt of implantable cardioverter deﬁbrillator (ICD) treatment.
In this study, we examined the importance of chronic psychological distress and device shocks among ICD
patients seen in clinical practice.
Methods: This prospective follow-up study included 589 patients with an ICD (mean age=62.6±10.1 years;
81% men). At baseline, vulnerability for chronic psychological distress was measured by the 14-item Type D
(distressed) personality scale. Cox regression models of all-cause and cardiac death were used to examine the
importance of risk markers.
Results: After a median follow-up of 3.2 years, 94 patients (16%) had died (67 cardiac death), 61 patients
(10%) had experienced an appropriate shock and 28 (5%) an inappropriate shock. Inappropriate shocks
were not associated with all-cause (p=0.52) or cardiac (p=0.99) death. However, appropriate shocks
(HR=2.60, 95% CI 1.47–5.58, p=0.001) and Type D personality (HR=1.85, 95% CI 1.12–3.05, p=0.015)
were independent predictors of all-cause mortality, adjusting for age, sex, left ventricular ejection fraction,
cardiac resynchronization therapy (CRT), secondary indication, history of coronary artery disease, medication
and diabetes. Type D personality and appropriate shocks also independently predicted an increased risk of
cardiac death. Other independent predictors of poor prognosis were older age, treatment with CRT and
diabetes.
Conclusion: Vulnerability to chronic psychological distress, as deﬁned by the Type D construct, had incremental
prognostic value above and beyond clinical characteristics and ICD shocks. Physicians should be aware of chronic
psychological distress and device shocks as markers of an increased mortality risk in ICD patients seen in daily
clinical practice.© 2012 Elsevier Ireland Ltd. All rights reserved.1. Introduction
The Multicenter Automatic Deﬁbrillator Implantation Trial II (MAD-
IT-II) [1] and Sudden CardiacDeath inHeart Failure Trial (SCD-HeFT) [2]
showed that implantable cardioverter deﬁbrillator (ICD) treatment
improves survival in patientswhoare at risk for ventricular arrhythmias
[3]. The combination with cardiac resynchronization therapy (CRT-D)
may further improve the clinical course of heart failure [4–6]. However,
in addition to these clinical trials, research needs to further examine the
outcome of ICD treatment in the real world of clinical practice [3].chology andNeuropsychology,
Netherlands. Tel.: +31 13 466
Ltd. All rights reserved.Secondary analyses of MADIT-II, SCD-HeFT and the Deﬁbrillation
in Acute Myocardial Infarction Trial (DINAMIT) have shown that ICD
shocks are associated with poor survival [7–9]. Advanced heart failure
and comorbid conditions may attenuate the survival beneﬁts of ICD
treatment in some patients [10–12]. Psychological distress may also
affect the cardiovascular system through several pathways [13–16],
especially through an important involvement of the autonomic
nervous system [17–19] and the induction of increased QT dispersion
[18,19], increased T-wave alternans [20,21] and arrhythmia [21–24].
Both ICD shocks [25] and Type D (distressed) personality [26] have
been related to distress. Type D is a propensity to chronic psychological
distress that has been shown to predict adverse events in cardiac
patients [27–29].
It has been argued thatmore research is needed on risk stratiﬁcation
among ICD patients seen in clinical practice [3,9]. Therefore, we wanted
to examine the importance of shocks and Type D personality as risk
markers of mortality following ICD treatment in the real world.
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2.1. Patient sample
Patients in the study had their ﬁrst ICD implanted between May 2003 and February
2009 in 2 Dutch referral hospitals (Amphia Hospital, Breda, and Catharina Hospital,
Eindhoven). Patients completed a psychological questionnaire at the time of implanta-
tion (between 1 day to 3 weeks after implantation). Patients who did not return the
questionnaire within 1 week received a reminder telephone call and a letter including
the questionnaire. Questionnaires were returned in a stamped, pre-addressed envelope
and were checked for completeness. Inclusion criteria were age between 18 and
80 years and sufﬁcient knowledge of Dutch; exclusion criteriawere cognitive impairment
(e.g. dementia) and psychiatric disorders except for affective disorders. From the 645
patients that were enrolled in the study, 56 had missing data on left ventricular ejection
fraction (LVEF) or shocks during follow-up or survival status. Hence, 589 patients (91%)
were included in the current analyses. The study was approved by the Medical Ethics
Committees of both participating hospitals,was conducted in accordancewith theHelsinki
Declaration, and all patients provided written informed consent. The authors of this
manuscript have certiﬁed that they comply with the Principles of Ethical Publishing in
the International Journal of Cardiology.
2.2. Shocks during follow-up
Shocks were considered to be appropriate if they were triggered by ventricular
tachycardia or ventricular ﬁbrillation [7] and inappropriate if they were triggered by
nonventricular arrhythmias or abnormal sensing [8]. Device interrogation was used
to obtain information on the nature of shocks as judged by electrophysiologists.
2.3. Type D (distressed) personality
Type D personality refers to an increased vulnerability for psychological distress
that predicts poor cardiovascular outcomes [27]. All patients completed the 14-item
Type D Scale (DS14) [28] at the time of implantation. The DS14 consists of two
7-item subscales, negative affectivity (e.g. “I often feel unhappy”) and social inhibition
(e.g. “I am a ‘closed’ person”). Items are scored on a 5-point Likert scale (subscale scores
from 0 to 28). Patients scoring high on both subscales, according to a standardized
cut-off score≥10, are classiﬁed as having a Type D personality. The DS14 is a reliable
scale, with Cronbach's alpha values of 0.88/0.86 and test–retest reliability over a
3-month period between r=0.72 and 0.82 [28].
2.4. End points
The end points were all-cause death and death from cardiac causes. Medical
records were checked to see whether the patient had a cardiologic check-up after
January 1, 2009. Patients who had a cardiologic check-up after this date were considered
alive and their follow-up date in the study was set as the most recent date they had a
check-up. For patients who did not have a check-up after January 1, 2009 or who died,
vital status or cause of death were discussed with the treating cardiologist and/or general
practitioner.
2.5. Cardiac and non-cardiac covariates
In order to examine the incremental value of shocks and distress as predictors of
mortality, a number of covariates were included as potential confounders in the
multivariable models. Cardiac covariates were obtained from themedical records at base-
line, and included left ventricular dysfunction (i.e., LVEF>35% versus LVEF≤35%), CRTTable 1
Covariates in the total study population, and stratiﬁed by survival status.
Characteristics Total sample
N=589
Stratiﬁed by survival status P value
Survivors
N=495
Non-survivors
N=94
Cardiac covariates
CRT 30% (175) 27% (133) 45% (42) 0.001
LVEF≤35% 83% (487) 81% (402) 90% (85) 0.030
Secondary indication 36% (210) 36% (176) 36% (34) 0.91
CAD 73% (428) 71% (353) 80% (75) 0.091
Beta-blockers 82% (481) 83% (411) 74% (70) 0.049
ACE-inhibitors 68% (400) 69% (340) 64% (60) 0.36
Non-cardiac covariates
Diabetes 19% (111) 17% (86) 27% (25) 0.036
Smoking 18% (106) 18% (89) 18% (17) 0.98
Male gender 81% (476) 80% (396) 85% (80) 0.25
No partner 13% (78) 14% (67) 12% (11) 0.63
CAD=coronary artery disease; CRT=cardiac resynchronization therapy; LVEF=left
ventricular ejection fraction; SD=standard deviation.
Bold values indicate signiﬁcance at pb0.05.(no/yes), ICD indication (primary prevention versus secondary prevention), coronary
artery disease (CAD; no/yes), beta-blockers, and ACE-inhibitors. Non-cardiac covariates
included diabetes mellitus (as reported in medical records), smoking status at baseline
(no/yes), and the demographics gender and marital status (having a partner versus
having no partner).
2.6. Statistical analyses
Chi-square tests were also used to determine potential differences in cardiac and
non-cardiac covariates stratiﬁed by survival status. A series of Cox regression analyses
were performed to determine the univariate predictive value of age, appropriate and
inappropriate shocks, Type D personality, and the cardiac and non-cardiac covariates
in relation to all-cause and cardiac-related mortality. Multivariable Cox regression
analyses were performed to determine the independent predictors for all-cause and
cardiac-related death. All tests were two-tailed and a p-valueb0.05was used to indicate
statistical signiﬁcance. All analyses were performed in PASW Statistics 17 forWindows.
3. Results
The mean age of the current cohort of ICD patients seen in clinical
practice was 62.6 years (SD=10.1 years); 476 (81%) were men and
the majority of patients had a partner (87%). The median follow-up
period was 3.2 years (range 0.8 to 6.5 years). During this period, 94
patients (16%) had died, with 67 (11%) due to a cardiac cause. There
were 61 patients (10%) who experienced an appropriate shock andYes
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Fig. 1. Survival of ICD patients over time (N=589), stratiﬁed by appropriate shocks (top)
and Type D personality (bottom). All-cause death (N=94) coded as 1. Multivariable
analyses, adjusted for age, cardiac covariates and non-cardiac covariates.
Table 2
Independent predictors of cardiac death in ICD patients.a
HR (95% CI) P value
Predictor variables
Type D personality 1.85 (1.03–3.32) 0.039
Appropriate shocks 2.26 (1.13–4.52) 0.021
Inappropriate shocks 0.99 (0.36–2.80) 0.99
Cardiac covariates
CRT 2.37 (1.29–3.88) 0.004
LVEF≤35% 1.50 (0.60–3.75) 0.39
Secondary indication 1.08 (0.60–1.92) 0.80
CAD 1.06 (0.57–1.95) 0.86
Beta-blockers 0.60 (0.35–1.04) 0.069
ACE-inhibitors 0.80 (0.48–1.37) 0.39
Non-cardiac covariates
Age (years) 1.06 (1.02–1.12) 0.001
Diabetes 1.70 (0.96–3.03) 0.069
Smoking 1.30 (0.69–2.46) 0.42
Male gender 1.10 (0.56–2.17) 0.78
No partner 0.70 (0.32–1.51) 0.36
CAD=coronary artery disease; CI=conﬁdence interval; CRT=cardiac resynchronization
therapy; HR=hazard ratio; LVEF=left ventricular ejection fraction.
Bold values indicate signiﬁcance at pb0.05.
a Multivariable Cox regression analysis.
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3.1. Covariates and mortality
Most patients in this cohort study had a LVEF≤35%, a history of
CAD, and received beta-blocker treatment (Table 1, total sample).
ICD patents that died during follow-up were signiﬁcantly more likely
to have a LVEF≤35%, and were more likely to be treated with CRT
(Table 1). Treatment with beta-blocker was associated with improved
survival rates, and a comorbid diagnosis of diabetes mellitus was also
more prevalent among non-survivors.
3.2. Shocks and Type D as predictors of all-cause mortality
At inclusion in the study, 134 (23%) of the patients were diagnosed
with a Type D personality. There were no signiﬁcant differences
between Type D and non-Type D individuals in LVEF (p=0.57), CRT
(p=0.30), secondary indication (p=0.80) or other baseline character-
istics. Survival curves showed that both appropriate shocks (Fig. 1, top)
and Type D personality (Fig. 1, bottom) were signiﬁcantly associated
with an increased risk for all-cause mortality. A multivariable Cox
regression model showed that both appropriate shocks (HR=2.60),
and Type D personality (HR=1.85) were independently associated
with an increased risk of all-cause mortality, adjusting for both cardiac
andnon-cardiac covariates (Fig. 2). Additional inclusion of inappropriate
shocks in the Cox model (data not shown) indicated that these shocks
were not associated with all-cause death (HR=0.72, 95% CI 0.26–1.98,
p=0.52). Age, CRT and diabetes were the only covariates that indepen-
dently predicted all-cause mortality.
3.3. Shocks and Type D as predictors of cardiac mortality
After adjustment for cardiac and non-cardiac covariates, Type D
personality (HR=1.85) and appropriate shocks (HR=2.26) were also
retained as independent predictors of cardiac death in the ﬁnal Cox
regression model (Table 2). Inappropriate shocks were not associated
with cardiac death (HR=0.99) in this Cox model. CRT and age alsoFig. 2. Independent predictors of all-cause mortality in ICD patients (N=589). Model estim
variable Cox regression analysis. CAD=coronary artery disease; CI=conﬁdence interval;
ejection fraction.independently predicted cardiac death (Table 2), and there was a trend
for beta-blockers and diabetes (p=.069).4. Discussion
Older age, appropriate shocks and Type D personality were inde-
pendently associated with an increased risk of all-cause and cardiac
death. The adverse effects of age and shocks in this clinical cohort of
ICD patients are consistent with reports from clinical ICD trials
[7–11]. The prognostic importance of Type D personality indicates
that psychological distress should also be considered as a potential
risk marker for poor survival in this patient population. Previously,
Type D personality has been related to an increased risk of emotional
distress [26] and ventricular arrhythmias [29] in ICD patients. Theates are presented as HRs with 95% CIs. Values were calculated with the use of multi-
CRT=cardiac resynchronization therapy; HR=hazard ratio; LVEF=left ventricular
2708 J. Denollet et al. / International Journal of Cardiology 167 (2013) 2705–2709present study showed that Type D personality also predicts an
increased long-term mortality risk, independent of ICD shocks.
Increasing age, treatment with CRT, and comorbid diabetes were
also associated with an increased mortality risk. This is consistent
with previous reports that age-related biological changes [30,31],
advanced heart failure and comorbid conditions [10–12] have an
adverse effect on cardiovascular outcomes. In this population of ICD
patients seen in clinical practice, shocks andTypeDwere both associated
with all-cause and cardiac death. Psychological distress induces in-
creased QT dispersion [18,19], T-wave alternans [20,21] and ventricular
arrhythmia [21–24,29], which result in an increased mortality risk.
Type D personality has also been related to a number of these mecha-
nisms [27], but more research is needed to determine the underlying
pathways bywhich TypeD is related to an increased risk of poor progno-
sis in ICD patients.
Interventions such as cognitive–behavioral therapy, stress man-
agement training and assertiveness training may be useful to improve
health-related behaviors and interpersonal functioning in Type D
patients, and to reduce their level of emotional distress [32]. Evidence
also suggests that behavioral intervention and exercise training may
enhance psychosocial functioning and reduce anxiety levels in
patients with an ICD [25,33]. Hence, future studies are warranted to
examine the degree to which these and other interventions are effec-
tive in improving cardiovascular outcomes, including survival, in ICD
patients with a Type D proﬁle.
The ﬁndings of this study should be interpreted with some
caution. Information on NYHA class was incomplete and therefore
not included in the analyses. We also had no data on pro brain-
natriuretic-peptide or on changes in LVEF or QRS duration that may
have occurred during follow-up. Diabetes did emerge as an indepen-
dent predictor of all-cause mortality, but other co-morbid conditions
that were not included may also affect survival, particularly in older
ICD patients. Strengths of this study are the real-world approach to
examine risk stratiﬁcation following ICD treatment in clinical practice
[3,12], the standardized assessment of Type D personality as a poten-
tial risk marker in ICD patients [34], the prospective study design, and
the use of all-cause mortality and cardiac death as clinical end-points.
A report from the National Heart, Lung, and Blood Institute and the
Heart Rhythm Society recommended the development of novel risk
stratiﬁcation strategies to improve outcomes in ICD patients [35].
This prospective study conﬁrms the prognostic role of ICD shocks,
and suggests that chronic psychological distress has incremental
prognostic value on par with the value of shocks and CRT. Cross-
cultural analysis of the Type D model in 6222 cardiac patients from
21 countries around the world supports the global validity of the
DS14 personality scale as a measure of chronic psychological distress
[36], including patients from Eastern cultures [37]. Overall, the ﬁnd-
ings of the present study indicate that physicians should be aware
of Type D personality and device shocks as independent markers of
an increased all-cause and cardiac mortality risk in ICD patients
seen in daily clinical practice.
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